Xiao YH. Bacterial resistance: challenge and strategies. China Lic Pharm
2011;8:3–8 (in Chinese).
Li YB, Xu J, Wang F, et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Affairs
Xiao Y, Hou F, Wang J, et al. An investigation into socio-economic impact of adverse drug reactions of antibacterial agent irrational use. Chin Health Econ
2010;29:94–96 (in Chinese).
Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health
Yang F, Liu SM. Attention to antibiotic resistance: the nightmare from medicine industry to food industry. Legal Syst Soc
2011;279:56–58 (in Chinese).
Li Y, Liu J, Xue F, et al. Antimicrobial susceptibility surveillance in China: a Mohnarin program 2007–2008 report. Chin J Clin Pharmacol
2011;27:323–334 (in Chinese).
Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: evidence from an audit study in China. J Health Econ
Chen M. Analysis on the condition of, reasons for and control on antibiotic abuse. Jiangsu Health Care Manage
2005;16:49–50 (in Chinese).
Ma Y. Rational use of antibiotics to inhibit the extension of bacterial resistance. China Pharm
2011;26:2401–2403 (in Chinese).
Wang CJ. Combat antibiotic abuse with multiple measures. Chin J Health
2011;5:40–41 (in Chinese).